Acute Stroke Clinical Trial
— MISTTOfficial title:
The Michigan Stroke Transitions Trial (MISTT): Improving Care Transitions for Acute Stroke Patients Through a Patient-centered Home Based Case Management Program
Verified date | July 2019 |
Source | Michigan State University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The Michigan Stroke Transitions Trial (MISTT) is a patient-centered randomized control trial that aims to improve the experience of stroke patients after they return home. The MISTT study will test the effect of two complementary interventions against usual care. The two interventions include: a) Stroke Case Managers (SCMs) who are trained social workers, and b) an online informational website or portal. The 12 week intervention period begins when the stroke patient returns home from the hospital or rehab facility. The SCMs will conduct at least 2 home visits with the patient (one within 3-4 days and one around 30 days) along with weekly follow-up telephone calls. Supplemental home visits will be used as necessary over the 12 week period. At the first home visit the social workers will conduct a comprehensive in-home assessment and link patients and caregivers to local resources as necessary. Patients also assigned to the website will have access to a patient-centered online information and support resource called the Virtual Stroke Support Portal (VSSP). The investigators hypothesize that this personalized case management program will reduce patient and caregiver needs, improve quality of life, and decrease caregiver stress. The MISTT study will enroll 315 acute stroke patients discharged from 3 Michigan hospitals and will be completed by the end of 2017.
Status | Completed |
Enrollment | 320 |
Est. completion date | November 30, 2017 |
Est. primary completion date | November 30, 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Patient Inclusion Criteria: - A final confirmed hospital diagnosis of acute stroke (ischemic or hemorrhagic). - Patient living at home pre-stroke. - Presence of stroke-related deficits at admission (defined as a National Institute of Health Stroke Severity score of >=1). - Presence of at least mild functional limitations at discharge (defined as a modified Rankin score [mRS] score of >=1), or therapy ordered. - Discharged directly home (includes patient's residence or that of a family member). - Discharged to a rehabilitation facility (IRF or SNF) with the expectation of return to home within 4 weeks. Patient Exclusion Criteria: - Patients who live more than 50 miles from the hospital (for reasons related to the home visits). - Patients discharged to nursing home, hospice care or LTCH (Long term care hospital). - Patients who have clinically documented cognitive deficits or stroke-related impairments including aphasia sufficient to impact the consent process and for whom a proxy respondent is not available. - Patients who fail the 6-item cognitive screening (SIS-6) for cognitive impairment (score <=4) and for whom a proxy respondent is not available - Patients enrolled in another acute stroke intervention trial that has a significant impact on the post-acute period (i.e., intensive data collection required of patient during follow-up). - Limited life expectancy (< 6 months) or significant medical comorbidity likely to impact completion of the study (e.g., severe mental illness, drug or alcohol use or dependence, metastatic cancer). - Neither the patient nor caregiver speaks English. Caregiver Inclusion Criteria: - Age 18 or over. - Are identified by the stroke patient as the primary caregiver (individual who has primary responsibility for assisting with the patient's care). - Speaks English. |
Country | Name | City | State |
---|---|---|---|
United States | University of Michigan | Ann Arbor | Michigan |
United States | Sparrow Health System | Lansing | Michigan |
United States | Saint Joseph Mercy Health System | Ypsilanti | Michigan |
Lead Sponsor | Collaborator |
---|---|
Michigan State University | Massachusetts General Hospital, Saint Joseph Mercy Health System, Sparrow Health System, University of Michigan |
United States,
Reeves MJ, Hughes AK, Woodward AT, Freddolino PP, Coursaris CK, Swierenga SJ, Schwamm LH, Fritz MC. Improving transitions in acute stroke patients discharged to home: the Michigan stroke transitions trial (MISTT) protocol. BMC Neurol. 2017 Jun 17;17(1):115. doi: 10.1186/s12883-017-0895-1. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | NeuroQOL Anxiety Scale (Patient) | Validated QOL scale measuring patient anxiety (administered by computer adaptive testing). | 90 day post discharge | |
Other | Depression Symptoms (PHQ-9) (Patient) | Validated 9-item questionnaire to identify depressive symptoms. | 90 day post discharge | |
Other | Hospital Readmission (Patient) | Unscheduled hospital admissions | 90 day post discharge | |
Other | Stroke Recurrence (Patient) | New onset acute stroke events requiring hospital admission | 90 day post discharge | |
Other | Home Time (Patient) | Total number of days spent at home since discharge back to home. | 90 day post discharge | |
Other | Oberst Caregiver Burden Scale (OCBS) (Caregiver) | Validated 15-item questionnaire measuring caregiver burden in response to providing care to stroke survivors. | 90 day post discharge | |
Other | Unhealthy Days (Caregiver) | Number of days in the past 30 days that the caregiver reported that their own physical or mental health had not been good. | 90-days post discharge | |
Other | PROMIS Emotional Support Scale (Caregiver). | A validated 4-item questionnaire measuring emotional support. Emotional support is defined as the perceived feeling of being cared for and valued as a person. | 90-days post discharge | |
Other | PROMIS Informational Support Scale (Caregiver). | A validated 4-item questionnaire measuring informational support. Informational support is defined as the perceived availability of helpful information or advice. | 90-days post discharge | |
Primary | Change From Baseline (7-days Post Discharge) to 90-days in the PROMIS-10 Global Quality of Life, Physical Health T-scores (Patient) | Patient-centered questionnaire of 10 self-reported items addressing the 2 main quality-of-life domains of physical and mental health which include physical health, physical function, pain, fatigue, quality of life, mental health, satisfaction with social activities, and emotional problems. PROMIS Global-10 Physical Health Quality-of-Life is a 4-item subscale measuring general aspects of physical health using a five-point Likert scale with higher scores reflecting better quality-of-life. Raw scores are summed and converted to a T-score which has a population mean score of 50 with standard deviation of 10; higher scores indicate better QOL (0-100). | 7 days and 90 days post discharge | |
Primary | Change From Baseline (7-days Post Discharge) to 90-days in the PROMIS-10 Global Quality of Life, Mental Health T-scores (Patient) | Patient-centered questionnaire of 10 self-reported items addressing the 2 main quality-of-life domains of physical and mental health which include physical health, physical function, pain, fatigue, quality of life, mental health, satisfaction with social activities, and emotional problems. PROMIS Global-10 Mental Health Quality-of-Life is a 4-item subscale measuring general aspects of physical health using a five-point Likert scale with higher scores reflecting better quality-of-life. Raw scores are summed and converted to a T-score which has a population mean score of 50 with standard deviation of 10; higher scores indicate better QOL (0-100). | 7 days and 90 days post discharge | |
Primary | Change From Baseline (7-days Post Discharge) to 90-days in the Bakas Caregiving Outcomes Scale Scores (Caregiver) | Instrument designed to measure perceived caregiver life changes in response to providing care to stroke survivors. Bakas is a 15-item measure using a rating scale with 7 points ranging from -3 (changed for the worse) to +3 (changed for the best); responses are converted to a 1-7 scale and summed (range 15-105). Higher scores indicate more positive changes resulting from caregiving experience whereas lower scores indicate negative changes. | 7 days and 90 days post discharge | |
Secondary | Change From Baseline (7-days Post Discharge) to 90-days in the Patient Activation Measure Scores (Patient) | Patient questionnaire to assess knowledge, skills, and self-efficacy for managing one's own healthcare. Patient Activation Measure is a 13-item survey using a five-point Likert scale (strongly disagree, disagree, agree, strongly agree, NA) whose response items are summed and converted to an activation score ranging from 0-100. Higher scores indicate a higher level of activation. | 7 days and 90 days post discharge | |
Secondary | Change From Baseline (7-days Post Discharge) to 90-days in Depression Symptoms (PHQ-9) (Caregiver) | The Patient Health Questionnaire (PHQ-9) measures severity of depression symptoms. PHQ-9 is a 9-item measure using a four-point Likert scale (not at all, several days, more than half the days, nearly every day). Response items are summed (range 0-27) with higher scores indicating the respondent is experiencing more symptoms of depression. | 7 days and 90 days post discharge |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03281590 -
Stroke and Cerebrovascular Diseases Registry
|
||
Enrolling by invitation |
NCT06074081 -
Comparison of 4-weeks of Motor Relearning Program and Mirror Therapy in Improving Upper Limb Motor Function in Stroke Patients.
|
N/A | |
Terminated |
NCT04039178 -
Efficacy of EMF BCI Based Device on Acute Stroke
|
N/A | |
Completed |
NCT04521634 -
Glycaemic Variability in Acute Stroke
|
||
Completed |
NCT03477188 -
The Effects of Somatosensory and Vestibular Rehabilitation Additional Conventional Therapy on Balance in Patients With Acute Stroke.
|
N/A | |
Recruiting |
NCT05065216 -
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
|
Phase 2/Phase 3 | |
Recruiting |
NCT02677415 -
Impact of Anesthesia Type on Outcome in Patients With Acute Ischemic Stroke (AIS) Undergoing Endovascular Treatment
|
N/A | |
Recruiting |
NCT01541163 -
Heart and Ischemic STrOke Relationship studY
|
N/A | |
Completed |
NCT01210729 -
Mechanical Recanalization With Flow Restoration in Acute Ischemic Stroke
|
Phase 2 | |
Recruiting |
NCT00785343 -
Study of Robot-assisted Arm Therapy for Acute Stroke Patients
|
Phase 1 | |
Completed |
NCT04779710 -
How Does Dysphagia Assessment in Acute Stroke Affect Pneumonia?
|
||
Active, not recruiting |
NCT03635749 -
Intensive Medical Therapy for High-risk Intracranial or Extracranial Atherosclerosis
|
Phase 3 | |
Recruiting |
NCT06149754 -
BraiN20® Monitoring in Acute Stroke Undergoing Thrombectomy
|
||
Recruiting |
NCT04491695 -
Tirofiban for the Prevention of Neurological Deterioration in Acute Ischemic Stroke
|
Phase 2/Phase 3 | |
Recruiting |
NCT04283760 -
Investigation of the Reliability and Validity of the Movement Imagination Questionnaire - Revised Second in Acute Stroke Patients
|
||
Recruiting |
NCT05454397 -
A Study on the Status of Nutritional Risk Screening and Nutritional Therapy in Neurology Hospitalized Stroke Patients
|
||
Completed |
NCT04488692 -
Early Functional Training in Acute Stroke Inpatient Ward
|
N/A | |
Recruiting |
NCT04214522 -
Reliability and Validity of the Kinesthetic and Visual Imagery Questionnaire in Acute Stroke Patients
|
||
Not yet recruiting |
NCT04157231 -
Essential Acute Stroke Care in Low Resource Settings: a Pilot studY
|
N/A | |
Recruiting |
NCT05469438 -
IMAS Optimization and Applicability in an Acute Stroke Setting.
|